ERNESTO
PÉREZ PERSONA
Fundación Jiménez Díaz
Madrid, EspañaPublications in collaboration with researchers from Fundación Jiménez Díaz (2)
2021
2020
-
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
British Journal of Haematology, Vol. 188, Núm. 5, pp. 661-673